EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy

Youyou Li, Jing Liu, Ralph R Weichselbaum, Wenbin Lin iD

Advanced Science · 2024-09 · 11 (35)

DOI: 10.1002/advs.202403520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.07.2024. Verfasst von Youyou Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Chicago, 929 East 57th Street, Chicago, IL, 60637, USA. Hauptthemen laut MEDLINE: Mitochondria, Immunotherapy, Nanoparticles, Down-Regulation. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of cuproptosis and immune checkpoint inhibition has shown promise in treating malignant tumors. However, it remains a challenge to deliver copper ions and immune checkpoint inhibitors efficiently and simultaneously to tumors. Herein, a mitochondria‐targeted nanoscale coordination polymer particle, Cu/TI, comprising Cu(II), and a triphenylphosphonium conjugate of 5‐carboxy‐8‐hydroxyquinoline (TI), for effective cuproptosis induction and programmed cell death‐1 (PD‐L1) downregulation is reported. Upon systemic administration, Cu/TI efficiently accumulates in tumor tissues to induce immunogenic cancer cell death and reduce PD‐L1 expression. Consequently, Cu/TI promotes the intratumoral infiltration and activation of cytotoxic T lymphocytes to greatly inhibit tumor progression of colorectal carcinoma and triple‐negative breast cancer in mouse models without causing obvious side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaImmunotherapyNanoparticlesDown-RegulationDisease Models, AnimalCopperAnimalsMiceHumansProgrammed Cell Death 1 ReceptorFemaleCell Line, TumorImmune Checkpoint InhibitorsB7-H1 AntigenTriple Negative Breast Neoplasms

Stichwörter der Autor:innen

PD‐L1 downregulationcancer immunotherapycuproptosismitochondria‐targetingnanomedicine

Substanzen

CopperProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsB7-H1 Antigen

Autor:innen und Institutionen

  • Department of Chemistry, University of Chicago, 929 East 57th Street, Chicago, IL, 60637, USA.
  • Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, University of Chicago, 5758 South Maryland Avenue, Chicago, IL, 60637, USA.

ORCID-Profile: Wenbin Lin

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Li, Y., Liu, J., Weichselbaum, R. R., & Lin, W. (2024). Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy. Advanced Science, 11(35). https://doi.org/10.1002/advs.202403520

Vancouver

Li Y, Liu J, Weichselbaum RR, Lin W. Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy. Advanced Science. 2024;11(35). doi:10.1002/advs.202403520

BibTeX
@article{Li2024,
  author = {Li, Youyou and Liu, Jing and Weichselbaum, Ralph R and Lin, Wenbin},
  title = {Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {35},
  doi = {10.1002/advs.202403520}
}
Kostenlos starten →